National Director, Communications
(240) 235-2204 | firstname.lastname@example.org
Bethesda, Md – CureSearch for Children’s Cancer announced the grant recipients of the CureSearch Community Impact Awards (CCIA). A total of $240,000 will be distributed to fourteen award recipients with projects having an impact on psychosocial resources for patients and families and caregiver resources.
“It’s critical for children and their families facing childhood cancer diagnoses to have the resources they need during this difficult time,” said Laura Thrall, CureSearch for Children’s Cancer chief executive officer. “Our CCIA Awards empower local medical communities to provide this much needed support.”
Launched in 2015, the CCIA Awards recognize the importance of community-based programs and innovative research in addressing the immediate needs of childhood cancer patients and finding cures.
The fourteen CCIA Award recipients are:
Variety Children’s Hospital dba Miami Children’s Hospital
Hurley Medical Center
Cleveland Clinic Foundation
Regents of the University of Minnesota – Twin Cities
Wake Forest University Health Sciences
Children’s Hospital Medical Center of Akron
Mary Baron Nelson
Children’s Hospital, Los Angeles
Los Angeles, CA
Rainbow Babies and Children’s Hospital (Cleveland, OH)
Inova Health Care Services
Stony Brook Foundation, Inc.
Stony Brook, NY
Wayne State University
Lehigh Valley Hospital, Inc.
Nemours Children’s Clinic – Jacksonville (Jacksonville, FL)
Mary Lou Schmidt
University of Illinois at Chicago – UIC
To learn more about the grant recipients and the CCIA program, click here.
CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md, works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch is building a $10 million research pipeline to aggressively drive pediatric research grants and clinical trials that have a higher chance of becoming cures for children’s cancer without the toxic side effects that plague current treatment options.